Papers

October 2015

New Treatment Perspectives in CLL: Using Disease and Patient Characteristics to Optimize Outcomes

April 2013

A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia

September 2012

Canadian Perspective on the Clinical Management of Metastatic Melanoma

November 2011

Managing hematological toxicities with FCR

May 2011

Developing a New Strategy for Rituximab Administration in Patients with CLL: The Ottawa Hospital Experience

March 2011

A Canadian Perspective on the Use of Biophosphonates in the Clinical Management of Multiple Myeloma

February 2011

Rituximab Rapid Infusion: From Research to Practice

March 2010

A Canadian Perspective on the Management of Chronic Lymphocytic Leukemia

February 2009

A Canadian Perspective for the Use of Rituximab in the Treatment of Chronic Lymphocytic Leukemia

Papers published in other journals

Current Oncology Vol 23, No 1 (2016)

A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia

Clinical Lymphoma, Myeloma & Leukemia - November 2015

Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.

Clinical Lymphoma, Myeloma & Leukemia - June 2015

A Canadian Perspective on the First-Line Treatment of Chronic Lymphocytic Leukemia

Current Oncology – Vol 22, No 4 (2015)

An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT

Current Oncology – Vol 22, No 2 (2015)

Melosky et al. Management of EGFR TKI-induced dermatologic adverse events

Current Oncology – Vol 21, No 6 (2014)

Hirsh et al. Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors

Current Oncology – Vol 21, No 5 (2014)

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Clinical Lymphoma, Myeloma & Leukemia – March (2014)

A Canadian Evidence-Based Guideline for the First-Line Treatment of Follicular Lymphoma: Joint Consensus of the Lymphoma Canada Scientific Advisory Board

Current Oncology – Vol 21, No 1 (2014)

A Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events